A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+-evoked [3H]-GABA release from rat hippocampal nerve terminals

Neuroscience Letters

Volumn 430, Issue 3, 2008, Pages 207-212

  Cunha Reis, Diana ^a   Ribeiro, Joaquim A ^a   Sebastião, Ana M ^a  

^a INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

Author keywords

A1; A2A; Adenosine; GABA release; Synaptosomes; VIP

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; VASOACTIVE INTESTINAL POLYPEPTIDE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINOBUTYRIC ACID; ADENOSINE RECEPTOR; DRUG DERIVATIVE; N(6) CYCLOPENTYLADENOSINE; N(6)-CYCLOPENTYLADENOSINE; PHENETHYLAMINE DERIVATIVE; POTASSIUM; TRITIUM; XANTHINE DERIVATIVE;

4 AMINOBUTYRIC ACID RELEASE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; SYNAPTOSOME; ANIMAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SECRETION; WISTAR RAT;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MALE; PHENETHYLAMINES; POTASSIUM; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; SYNAPTIC TRANSMISSION; SYNAPTOSOMES; TRITIUM; VASOACTIVE INTESTINAL PEPTIDE; XANTHINES;

EID: 38049094945     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.10.037     Document Type: Article

References (29)

1. Acsády L., Arabadzisz D., and Freund T.F. Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in the rat hippocampus. Neuroscience 73 (1996) 299-315
2. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 335 (1987) 59-63
3. 3H]-NECA in rat striatal membranes. Mol. Pharmacol. 29 (1986) 331-346
4. Casabona G., L'Episcopo M.R., Di Iorio P., Ciccarelli R., De Bernardis E., Shinozaki H., Nicoletti F., and Caciagli F. Interaction between metabotropic receptors and purinergic transmission in rat hippocampal slices. Brain Res. 645 (1994) 13-19
5. 3H]-ACh release from the rat motor nerve terminals. Neurosci. Lett. 309 (2001) 101-104
6. 2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br. J. Pharmacol. 122 (1997) 1279-1284
7. 2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. Neurosci. Lett. 196 (1995) 41-44
8. 2A receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 353 (1996) 261-271
9. 3H]-GABA release from rat hippocampal nerve terminals. Neuropharmacology 39 (2000) 1156-1167
10. Cunha-Reis D., Sebastião A.M., Wirkner K., Illes P., and Ribeiro J.A. VIP enhances both pre- and post-synaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells. Br. J. Pharmacol. 143 (2004) 733-744
11. 2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampus. Neuropharmacology 52 (2007) 313-350
12. AHP, by reducing adenylyl cyclise activity in rat CA3 hippocampal neurons. J. Neurophysiol. 72 (1994) 2360-2367
13. Haas H.L., and Gähwiller B.H. Vasoactive intestinal polypeptide modulates neuronal excitability in hippocampal slices of the rat. Neuroscience 47 (1992) 273-277
14. 3H]-CGS21680. Eur. J. Pharmacol. 168 (1989) 243-246
15. Lambert N.A., and Teyler T.J. Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus. Neurosci. Lett. 122 (1991) 50-52
16. Li H., and Henry J.L. Adenosine action on interneurons and synaptic transmission onto interneurons in rat hippocampus in vitro. Eur. J. Pharmacol. 407 (2000) 237-244
17. 3H]-CGS21680 in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 539-541
18. 1 receptor responses. Eur. J. Pharmacol. 383 (1999) 395-398
19. 1 receptor-specific monoclonal antibody. J. Comp. Neurol. 411 (1999) 301-316
20. 2A selective adenosine receptor antagonist. Br. J. Pharmacol. 115 (1995) 1096-1102
21. Rosenberg P.A., and Li Y. Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures. Neurosci. Lett. 200 (1995) 93-96
22. Sakai K., and Saito K. Reciprocal interactions among neuropeptides and adenosine in the cardiovascular system of rats: a role of K (ATP) channels. Eur. J. Pharmacol. 345 (1998) 279-284
23. Saransaari P., and Oja S.S. GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions. Neurochem. Res. 30 (2005) 467-473
24. Sebastião A.M., and Ribeiro J.A. Fine-tuning neuromodulation by adenosine. Trends Pharmacol. Sci. 21 (2000) 341-346
25. Wang H.-L., Li A., and Wu T. Vasoactive intestinal polypeptide enhances the GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res. 746 (1997) 294-300
26. 1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue. Naunyn-Schmiedeberg's Arch. Pharmacol. 332 (1986) 179-183
27. Wright R.A., and Schoepp D.D. Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus. Eur. J. Pharmacol. 297 (1996) 275-282
28. Yoon K.-W., and Rothman S.M. Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J. Neurosci. 11 (1991) 1375-1380
29. 2A adenosine receptor antagonist, to rat striatal membranes. Br. J. Pharmacol. 117 (1996) 1381-1386